The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
Abstract
Summary null Although recent technical advances in thrombectomy have revolutionised acute stroke treatment, prevalence of disability and death related to stroke remain high. Therefore, plasminogen activators—eukaryotic, bacterial, or engineered forms that can promote fibrinolysis by converting plasminogen into active plasmin and facilitate clot breakdown—are still commonly used in the acute treatment of ischaemic stroke. Hence, plasminogen...
Paper Details
Title
The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
Published Date
Dec 1, 2018
Journal
Volume
17
Issue
12
Pages
1121 - 1132
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History